Phicha Limtrakarn currently serves as the Chief Strategy Officer at Novo Nordisk since March 2025 and has held various shareholder positions at companies such as Bristol Myers Squibb, Virgin Galactic, Telefónica, Gran Tierra Energy, UBS, and Syfe since 2023. Additionally, Phicha works in securities at Tiger Brokers Singapore and as a Business Analyst at Amway Thailand since April 2020. Phicha is also a Business Development Specialist at Nu Skin since April 2015. Phicha holds a Master of Business Administration (MBA) in International Business/Trade/Commerce from UNSW, completed from February 2000 to August 2001.
This person is not in any teams
This person is not in any offices